Amgen (AMGN) Other Non-Current Assets (2009 - 2026)

Amgen (AMGN) has reported Other Non-Current Assets for 18 consecutive years, with $12.8 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 12.05% year-over-year to $12.8 billion; the TTM figure through Mar 2026 stood at $12.8 billion (up 12.05% YoY), while the FY2025 annual figure was $12.7 billion, up 27.49% from the prior year.
• Other Non-Current Assets came in at $12.8 billion for Q1 2026 at Amgen, up from $12.7 billion in the prior quarter.
• The five-year high for Other Non-Current Assets was $13.2 billion in Q3 2025, with the low at $5.9 billion in Q4 2022.
• Average Other Non-Current Assets over 5 years is $9.2 billion, with a median of $9.0 billion recorded in 2024.
• Across the five-year window, Other Non-Current Assets slipped 9.58% in 2022 and jumped 62.93% in 2023, its largest moves.
• Year by year, Other Non-Current Assets stood at $5.9 billion in 2022, then surged by 62.93% to $9.6 billion in 2023, then increased by 3.32% to $9.9 billion in 2024, then increased by 27.49% to $12.7 billion in 2025, then gained by 0.79% to $12.8 billion in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $12.8 billion, $12.7 billion, and $13.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.